Could nonthermal tumor ablation replace surgery for low-risk thyroid cancer? Pulse Biosciences launches feasibility study
Pulse Biosciences begins human study of nsPFA thyroid cancer treatment. Discover what this trial could mean for minimally invasive oncology.